Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Alliance Pharmaceuticals
Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
Telephone: +44 (0)1249 466 966
Fax: +44 (0)1249 466 977
WWW: http://www.alliancepharma.co.uk
Medical Information e-mail: medinfo@alliancepharma.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 03/11/2009
SPC Aquadrate 10% w/w Cream

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to separate SPCs covering individual presentations
Date of revision of text on the SPC:   05-Dec-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
SmPC separated for Aquadrate and Hydromol Intensive
Updated on 06/04/2009 and displayed until 03/11/2009
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
Date of revision of text on the SPC:   05-Dec-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 1- The folllowing text has been added:


Hydromol Intensive
Updated on 25/05/2006 and displayed until 06/04/2009
Reasons for adding or updating:
  • Change to section 1 - trade name
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   10/05/2006
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 1 the name of the product has changed from Aquadrate Cream to Aquadrate 10% w/w Cream.
 
Section 4.8 (undesirable effects) local irritations (including erythema, burning or pruritus) [when applied to sensitive, moist or fissured skin] have been added and stinging has been removed.
Updated on 01/04/2005 and displayed until 25/05/2006
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change from the BAN of the active substance to the rINN
Updated on 01/04/2005 and displayed until 01/04/2005
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change from the BAN of the active substance to the rINN
Updated on 17/05/2002 and displayed until 01/04/2005
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder

Active Ingredients/Generics

 
  urea